Frequently Asked Questions

InMed Pharmaceuticals Inc. Share Consolidation

InMed Pharmaceuticals Inc. (“InMed”, “Company”) is planning to implement a 33:1 share consolidation in the coming weeks (estimated for late June or early July).  This FAQ document is designed to help shareholders understand what this means.

1. What is a share consolidation?

Learn more

2. Why is InMed undergoing a share consolidation?

Learn More

3. What happens to my investment? What will my shares be worth?

Learn More

4. How does this impact my ownership position in InMed?

Learn More

5. How much money will I lose on the consolidation?

Learn More

6. When is the consolidation planned?

Learn More

7. How will my broker know how many new shares I have?

Learn More

8. Will the CUSIP/ISIN numbers change?

Learn More

9. What happens to stock options?

Learn More

10. Will the consolidation increase the share price over the long-term?

Learn More